These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24422938)

  • 1. Response to open peer commentaries on "prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults".
    Dubljević V
    Am J Bioeth; 2014; 14(1):W1-8. PubMed ID: 24422938
    [No Abstract]   [Full Text] [Related]  

  • 2. Tobacco: prohibition, coffee shops, or discouragement?
    van der Eijk Y
    Am J Bioeth; 2013; 13(7):51-3. PubMed ID: 23767444
    [No Abstract]   [Full Text] [Related]  

  • 3. Prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults.
    Dubljević V
    Am J Bioeth; 2013; 13(7):23-33. PubMed ID: 23767434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement policy and the value of information.
    Sandberg A
    Am J Bioeth; 2013; 13(7):34-5. PubMed ID: 23767435
    [No Abstract]   [Full Text] [Related]  

  • 5. Moving beyond methylphenidate and amphetamine: the ethics of a better "smart drug".
    LaBuzetta JN
    Am J Bioeth; 2013; 13(7):43-5. PubMed ID: 23767440
    [No Abstract]   [Full Text] [Related]  

  • 6. The indirect psychological costs of cognitive enhancement.
    Faulmüller N; Maslen H; de Sio FS
    Am J Bioeth; 2013; 13(7):45-7. PubMed ID: 23767441
    [No Abstract]   [Full Text] [Related]  

  • 7. How research on stakeholder perspectives can inform policy on cognitive enhancement.
    Forlini C; Racine E; Vollmann J; Schildmann J
    Am J Bioeth; 2013; 13(7):41-3. PubMed ID: 23767439
    [No Abstract]   [Full Text] [Related]  

  • 8. An argument for permitting amphetamines and instant-release methylphenidate.
    Flanigan J
    Am J Bioeth; 2013; 13(7):49-51. PubMed ID: 23767443
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating methylphenidate: enhancing cognition and social inequality.
    Brewer CD; DeGrote H
    Am J Bioeth; 2013; 13(7):47-9. PubMed ID: 23767442
    [No Abstract]   [Full Text] [Related]  

  • 10. A liberal consequentialist approach to regulation of cognitive enhancers.
    Savulescu J
    Am J Bioeth; 2013; 13(7):53-5. PubMed ID: 23767445
    [No Abstract]   [Full Text] [Related]  

  • 11. Some first steps toward responsible use of cognitive-enhancing drugs by the healthy.
    Greely HT
    Am J Bioeth; 2013; 13(7):39-41. PubMed ID: 23767438
    [No Abstract]   [Full Text] [Related]  

  • 12. There may be costs to failing to enhance, as well as to enhancing.
    Levy N
    Am J Bioeth; 2013; 13(7):38-9. PubMed ID: 23767437
    [No Abstract]   [Full Text] [Related]  

  • 13. Constraints on regulatory options for putatively cognitive enhancing drugs.
    Hall W; Partridge B; Lucke J
    Am J Bioeth; 2013; 13(7):35-7. PubMed ID: 23767436
    [No Abstract]   [Full Text] [Related]  

  • 14. Tightening the Dutch coffee shop policy: Evaluation of the private club and the residence criterion.
    van Ooyen-Houben MM; Bieleman B; Korf DJ
    Int J Drug Policy; 2016 May; 31():113-20. PubMed ID: 26944718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats.
    Valvassori SS; Frey BN; Martins MR; Réus GZ; Schimidtz F; Inácio CG; Kapczinski F; Quevedo J
    Behav Pharmacol; 2007 May; 18(3):205-12. PubMed ID: 17426484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gammahydroxybutyrate must remain available for patients with narcolepsy].
    Lammers GJ; van Dijk JG; Ferrari MD; van Gerven JM; Declerck AC; Troost J
    Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2062-3. PubMed ID: 10560549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Governments needs to explore alternative to prohibitionist drug policies, says report.
    Sweet M
    BMJ; 2012 Apr; 344():e2610. PubMed ID: 22492117
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of the abuse potential of modafinil using methylphenidate as a reference.
    Jasinski DR
    J Psychopharmacol; 2000 Mar; 14(1):53-60. PubMed ID: 10757254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who is using the drugs I prescribe?
    Winkelaar PG
    Can Fam Physician; 2002 May; 48():883. PubMed ID: 12053632
    [No Abstract]   [Full Text] [Related]  

  • 20. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models.
    Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF
    J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.